| |
| |
|
| Insider
Information: |
Gerngross Tillman U. |
| Relationship: |
Chief Executive Office... |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
3,037,140 |
|
|
Indirect Shares
|
27,845,995 |
|
|
| Direct
Value |
$14,443,066 |
|
|
|
Indirect Value
|
$69,893,447 |
|
|
| Total
Shares |
30,883,135 |
|
|
| Total
Value |
$84,336,513 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
X4 Pharmaceuticals Inc |
XFOR |
Director |
2017-11-20 |
392,821 |
2017-11-20 |
0 |
Premium* |
|
|
Alector, Inc. |
ALEC |
|
2023-06-14 |
2,644,319 |
2019-02-11 |
0 |
Premium* |
|
|
Adagio Therapeutics, Inc. |
ADGI |
Chief Executive Office... |
|
0 |
2021-08-10 |
27,845,995 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALEC |
Alector, Inc. |
|
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
2,644,319 |
0 |
- |
|
| ALEC |
Alector, Inc. |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,459 |
2,618,069 |
0 |
- |
|
| ADGI |
Adagio Therapeutics, Inc. |
Chief Executive Officer |
• • • |
2021-08-10 |
4 |
A |
$0.00 |
$0 |
I/I |
25,860,700 |
27,845,995 |
0 |
- |
|
| ADGI |
Adagio Therapeutics, Inc. |
Chief Executive OfficerOfficer |
• • • |
2021-08-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,985,295 |
|
- |
|
| ALEC |
Alector, Inc. |
Director |
– • – |
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
427,292 |
2,608,610 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Director |
– • – |
2017-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
90,272 |
192,821 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
Director |
– • – |
2017-11-20 |
4 |
B |
$10.00 |
$2,000,000 |
D/D |
200,000 |
392,821 |
2.39 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
